Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-99.90	21.08	-22005.36
Graham Fair Price	80.35	14.09	7.81
PEG	-87.64	0.06	-0.51
Price/Book	-10.61	0.66	0.74
Price/Cash Flow	15.45	39.63	34.33
Prices/Earnings	-70.69	13.80	47.08
Price/Sales	-40.51	9.10	15.30
Price/FCF	15.45	39.63	34.33
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	7.87	0.52	0.48
Operating Margin	49.92	0.11	-0.07
ROA	193.74	< 0.005	< 0.005
ROE	< 0.005	0.01	204.96
ROIC	< 0.005	< 0.005	46.10
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.14	0.23	-38.89
Dividends QOQ	14.05	4.21	-70.03
EBIT QOQ	-1.06	3.28	210.68
EPS QOQ	-0.93	2.20	137.19
FCF QOQ	8.46	-0.22	-97.45
Revenue QOQ	-0.07	0.52	626.74
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	129.93	119.85	-7.76
Days Sales Outstanding (DSO)	122.68	120.79	-1.55
Inventory Turnover	0.69	0.75	8.41
Debt/Capitalization	0.01	0.01	12.47
Quick Ratio	4.06	3.22	-20.67
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	26.35	27.21	3.27
Cash	11.93	11.81	-1.02
Capex	-0.07	-0.06	16.73
Free Cash Flow	0.56	0.45	-20.04
Revenue	1.27	1.97	55.19
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	4.50	3.73	-17.10
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	25188.72	-28.63	-99.89
Naive Interpretation	Member

06 - Financial Health · Bad

Rating